Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Breier

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Schizophrenia Bulletin|September 10, 2005
Developing drugs for cognitive impairment in schizophreniaAlan Breier
The American Journal of Psychiatry|October 5, 2011
Anxiety disorders and antipsychotic drugs: a pressing need for more researchAlan Breier
Diabetes Care|October 28, 2003
Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes: response to Lean and PajonkThomas Hardy, Alan Breier
Schizophrenia Bulletin|June 15, 2007
Wayne Fenton's impact on industryAlan Breier, Larry Alphs, Brendon Binneman
Biological Psychiatry|August 7, 2024
Altered Vesicular Acetylcholine Transporter Availability in Schizophrenia: Association With Positive Symptoms and Cognitive ImpairmentSamantha E Yohn, Alan Breier, Steven M Paul
The British Journal of Psychiatry. Supplement|April 2, 2004
Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medicationsPatrizia Cavazzoni, Nitai Mukhopadhyay, Christopher Carlson, et al.
Journal of Psychiatric Research|October 26, 2021
Site-independent confirmation of primary site-based PANSS ratings in a schizophrenia trialSteven D Targum, Christopher Murphy, Alan Breier, et al.
Disaster Medicine and Public Health Preparedness|August 6, 2023
Psychosis, Telehealth, and COVID-19: Engagement and Hospitalization Pre- and Peri-PandemicSerena Chaudhry, Robert Roy, Kasra Mansourian, et al.
Early Intervention in Psychiatry|January 27, 2025
Criminal Offending and Incarceration in United States Adults With Early Phase Psychosis and Comorbid Substance Use DisorderKyle D Webster, Tracy D Gunter, Jenifer L Vohs, et al.
Journal of Affective Disorders|September 1, 2004
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acidMadhav A Namjoshi, Richard Risser, Lizheng Shi, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Schizophrenia Bulletin|September 10, 2005
Developing drugs for cognitive impairment in schizophreniaAlan Breier
The American Journal of Psychiatry|October 5, 2011
Anxiety disorders and antipsychotic drugs: a pressing need for more researchAlan Breier
Diabetes Care|October 28, 2003
Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes: response to Lean and PajonkThomas Hardy, Alan Breier
Schizophrenia Bulletin|June 15, 2007
Wayne Fenton's impact on industryAlan Breier, Larry Alphs, Brendon Binneman
Biological Psychiatry|August 7, 2024
Altered Vesicular Acetylcholine Transporter Availability in Schizophrenia: Association With Positive Symptoms and Cognitive ImpairmentSamantha E Yohn, Alan Breier, Steven M Paul
The British Journal of Psychiatry. Supplement|April 2, 2004
Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medicationsPatrizia Cavazzoni, Nitai Mukhopadhyay, Christopher Carlson, et al.
Journal of Psychiatric Research|October 26, 2021
Site-independent confirmation of primary site-based PANSS ratings in a schizophrenia trialSteven D Targum, Christopher Murphy, Alan Breier, et al.
Disaster Medicine and Public Health Preparedness|August 6, 2023
Psychosis, Telehealth, and COVID-19: Engagement and Hospitalization Pre- and Peri-PandemicSerena Chaudhry, Robert Roy, Kasra Mansourian, et al.
Early Intervention in Psychiatry|January 27, 2025
Criminal Offending and Incarceration in United States Adults With Early Phase Psychosis and Comorbid Substance Use DisorderKyle D Webster, Tracy D Gunter, Jenifer L Vohs, et al.
Journal of Affective Disorders|September 1, 2004
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acidMadhav A Namjoshi, Richard Risser, Lizheng Shi, et al.
Pageof 11